Sumitomo Pharma (OTCMKTS:DNPUF) Stock Price Up 4% – Here’s What Happened

Sumitomo Pharma Co., Ltd. (OTCMKTS:DNPUF) rose 4% on Tuesday . The company traded as high as $11.50 and last traded at $11.50. Approximately 150 shares changed hands during mid-day trading, a decline of 93% from the average daily volume of 2,250 shares. The stock had previously closed at $11.06.

Sumitomo Pharma Stock Performance

The business’s 50 day simple moving average is $14.28 and its 200 day simple moving average is $13.43.

Sumitomo Pharma Company Profile

Sumitomo Pharma Co, Ltd., trading OTC under the ticker DNPUF, is a global pharmaceutical company headquartered in Osaka, Japan. It engages in the research, development, manufacturing and marketing of prescription medicines. As part of the broader Sumitomo Group, the company applies integrated drug discovery platforms and collaborative partnerships to bring innovative therapies to market.

The company’s portfolio encompasses central nervous system disorders, oncology, immunology and regenerative medicine.